ARCHIVES

In Congress: Tamoxifen Results Well Communicated, Understood, NCI Says

This article is from The Cancer Letter archive.

Vol. 24 No. 17 | May 1, 1998

Download PDF Visit The Full Archive

Related Articles

Study Identifies Characteristics That Promote Early-Life NHL

May 25, 2012

In Surprising Result, Survey Of Centers Finds Little “Crisis” In Clinical Research

September 29, 1995

Former NCAB chairman, President’s Cancer Panel member Paul Calabresi dead at 73.

October 31, 2003

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

New Two-Step Matching Process Increases Success of Transplants

September 30, 2011

New Awards for New Investigators To Replace R-23 Grants

November 8, 1985